According to the FDA, 23 GI drugs are facing active shortages.
Twenty-three GI drugs in shortage:
1. Amino acids
2. Bacteriostatic 0.9% sodium chloride injection
3. Calcium gluconate injection
4. Dexamethasone sodium phosphate injection
5. Dextrose 5% injection
6. Dextrose 10% injection
7. Dextrose 25% injection
8. Dextrose 50% injection
9. Lipid injection
10. Multivitamin infusion (adult and pediatric)
11. Nizatidine capsules
12. Pantoprazole sodium for injection
13. Potassium acetate injection
14. Potassium chloride concentrate injection
15. Promethazine (Phenergan) injection
16. Sodium acetate injection
17. Sodium bicarbonate injection
18. Sodium chloride 0.9% injection bags
19. Sodium chloride 14.6% injection
20. Sodium chloride 23.4% injection
21. Sodium phosphates injection
22. Sulfasalazine tablets
23. Trimethobenzamide hydrochloride capsules
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.